Abstract
Objective A major limitation of current suicide research is the lack of power to identify robust correlates of suicidal thoughts or behaviour. Variation in suicide risk assessment instruments used across cohorts may represent a limitation to pooling data in international consortia.
Method Here, we examine this issue through two approaches: (i) an extensive literature search on the reliability and concurrent validity of the most commonly used instruments; and (ii) by pooling data (N∼6,000 participants) from cohorts from the ENIGMA-Major Depressive Disorder (ENIGMA-MDD) and ENIGMA-Suicidal Thoughts and Behaviour (ENIGMA-STB) working groups, to assess the concurrent validity of instruments currently used for assessing suicidal thoughts or behaviour.
Results Our results suggested a pattern of moderate-to-high correlations between instruments, consistent with the wide range of correlations, r=0.22-0.97, reported in the literature. Two common complex instruments, the Columbia Suicide Severity Rating Scale (C-SSRS) and the Beck Scale for Suicidal Ideation (SSI), were highly correlated with each other (r=0.83), as were suicidal ideation items from common depression severity questionnaires.
Conclusions Our findings suggest that multi-item instruments provide valuable information on different aspects of suicidal thoughts or behaviour, but share a core factor with single suicidal ideation items found in depression severity questionnaires. Multi-site collaborations including cohorts that used distinct instruments for suicide risk assessment should be feasible provided that they harmonise across instruments or focus on specific constructs of suicidal thoughts or behaviours.
Key points
Question: To inform future suicide research in multi-site international consortia, it is important to examine how different suicide measures relate to each other and whether they can be used interchangeably.
Findings: Findings suggest detailed instruments (such as the Columbia Suicide Severity Rating Scale and Beck Scale for Suicidal Ideation) provide valuable information on suicidal thoughts and behaviour, and share a core factor with items on suicidal ideation from depression severity rating scale (such as the Hamilton Depression Rating Scale or the Beck Depression Inventory).
Importance: Results from international collaborations can mitigate biases by harmonising distinct suicide risk assessment instruments.
Next steps: Pooling data within international suicide research consortia may reveal novel clinical, biological and cognitive correlates of suicidal thoughts and/or behaviour.
Competing Interest Statement
EV has received grants and served as consultant, advisor or CME speaker for the following entities: AB-Biotics, Abbott, AbbVie, Angelini, Boehringer-Ingelheim, Dainippon Sumitomo Pharma, Ferrer, Gedeon Richter, GH Research, Janssen, Lundbeck, Novartis, Otsuka, Sage, Sanofi-Aventis, Sunovion, and Takeda, outside the submitted work. CAZ is a full-time U.S. government employee. He is listed as a co-inventor on a patent for the use of ketamine and its metabolites in major depression and suicidal ideation. CAZ has assigned his patent rights to the U.S. government but will share a percentage of any royalties that may be received by the government. NJ and PMT received partial grant support from Biogen, Inc. (Boston, USA) for research unrelated to this manuscript. NV has received financial support for CME activities and travel funds from the following entities (unrelated to the present work): Angelini, Janssen, Lundbeck, Otsuka. EO has received consultancy honoraria from Janssen Cilag. KJR serves on advisory boards for Takeda, Janssen, and Verily, and he has received sponsored research support from Alkermes, Alto Neuroscience, and Brainsway, and he receives funding from NIH and the Brain and Behavior Research Fund. JDS has received funding via an honorarium associated with a lecture for Wyeth and funding from Indivior for a study on opioid dependency. DJS has received research grants and/or consultancy honoraria from Lundbeck, Johnson & Johnson, Servier, and Takeda.
Funding Statement
MER received support from the Australian National Health and Medical Research Council Centre for Research Excellence on Suicide Prevention CRESP GNT1042580 LS LvV LC HPB ALvH SB and MD were supported by the MQ Brighter Futures Award MQBFC2 LvV LS and NJ were supported by the National Institute of Mental Health of the National Institutes of Health under Award Number R01MH117601 LS is supported by a NHMRC Career Development Fellowship 1140764 HPB was additionally supported by R61MH111929RC1MH088366 R01MH070902 R01MH069747 American Foundation for Suicide Prevention International Bipolar Foundation Brain and Behavior Research Foundation For the Love of Travis Foundation and Women s Health Research at Yale LC was additionally supported by Interdisziplinares Zentrum fur Klinische Forschung UKJ PMT was supported in part by NIH grant R01 MH116147 FJ would like to thank dr Richard-Devantoy for his assistance during data collection This work was supported by the CIBERSAM and the Catalonian Government 2014 SGR 1573 and 2017 SGR 1271 to FIDMAG PFC is funded by the Instituto de Salud Carlos III cofunded by European Union ERDF ESF Investing in your future Sara Borrell contract CD19 00149 The researchers based in Milan were supported by an Italian Ministry of Health grant RF 2011 02349921 ALvH was funded through the Leiden University Social Safety and Resilience Programme The NIMH ETPB team was supported by the Intramural Research Program at the National Institute of Mental Health National Institutes of Health IRP NIMH NIH ZIAMH002927 MS is supported by the Phyllis and Jerome Lyle Rappaport Foundation Ad Astra Chandaria Foundation BIAL Foundation Brain and Behavior Research Foundation Anonymous donors and the Center for Depression Anxiety and Stress Research at McLean Hospital The team based at the University of Minnesota was supported by the National Institute of Mental Health K23MH090421 the National Alliance for Research on Schizophrenia and Depression the University of Minnesota Graduate School the Minnesota Medical Foundation and the Biotechnology Research Center P41 RR008079 to the Center for Magnetic Resonance Research University of Minnesota and the Deborah E Powell Center for Women s Health Seed Grant IHG was supported by the National Institute of Mental Health grant R37MH101495 EV thanks the support of the Spanish Ministry of Science and Innovation PI1500283 PI1800805 integrated into the Plan Nacional de I D I and cofinanced by the ISCIII Subdireccion General de Evaluacion and the Fondo Europeo de Desarrollo Regional FEDER the Instituto de Salud Carlos III the CIBER of Mental Health CIBERSAM the Secretaria dUniversitats i Recerca del Departament d Economia i Coneixement 2017 SGR 1365 the CERCA Programme and the Departament de Salut de la Generalitat de Catalunya for the PERIS grant SLT006 17 00357 NV thanks the support of a BITRECS project that has received funding from the European Unions Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 754550 and from La Caixa Foundation ID 100010434 under the agreement LCF PR GN18 50310006 For the team in Nimes CINES grants access to HPC facilities A0100311413 The team based in Rome was supported by an Italian Ministry of Health grant RC17 18 19 20 21A Support for the TIGER study includes the Klingenstein Third Generation Foundation the National Institute of Mental Health K01MH117442 the Stanford Maternal Child Health Research Institute and the Stanford Center for Cognitive and Neurobiological Imaging TCH receives partial support from the Ray and Dagmar Dolby Family Fund The UCSF site was supported by the National Center for Complementary and Integrative Health NCCIH R21AT009173 and R61AT009864 to TTY by the National Center for Advancing Translational Sciences CTSI National Institutes of Health through UCSF CTSI UL1TR001872 to TTY by the American Foundation for Suicide Prevention AFSP SRG 1 141 18 to TTY by UCSF Research Evaluation and Allocation Committee REAC and J Jacobson Fund to TTY by the National Institute of Mental Health NIMH R01MH085734 and the Brain and Behavior Research Foundation to TTY The team at Duke University Durham VA medical center were supported by the VA Mid Atlantic Mental Illness Research Education and Clinical Center MIRECC The Moral Dilemma study was supported by the Brain and Behavior Research Foundation and by the National Health and Medical Research Council ID 1125504 to SLW The FOR2107 Marburg site was supported by the German Research Foundation DFG grant FOR2107 KI588 14 1 and FOR2107 KI588 14 2 to Tilo Kircher Marburg The FOR2107 Muenster site was supported by the German Research Foundation DFG grant FOR2107 DA1151 5 1 and DA1151 5 2 to UD SFB TRR58 Projects C09 and Z02 to UD and the Interdisciplinary Center for Clinical Research ZKF of the medical faculty of Munster grant Dan3 012 17 to UD CGD and BJH were supported by the National Health and Medical Research Council of Australia NHMRC Project Grants 1064643 and 1024570 NF was supported by the National Institute of Mental Health MH111671 and National Center for Complementary and Integrative Health R01AT011267 TJ was supported by the National Institutes Health Project Grants MH098212 to TJ JR and LF thank the support of the Spanish Ministry of Science and Innovation PI19 00394 and CPII19 00009 integrated into the Plan Nacional de I D I and co-financed by the ISCIII Subdireccion General de Evaluacion and the Fondo Europeo de Desarrollo Regional FEDER the Instituto de Salud Carlos III the CIBER of Mental Health CIBERSAM YH AN and ES were supported by AMED Brain MINDS Beyond program Grant No 20dm0307002 YH was supported by JSPS KAKENHI Grants No 19K03309.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All participants provided informed consent and all projects were approved by their respective relevant ethics committees
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Disclosures: EV has received grants and served as consultant, advisor or CME speaker for the following entities: AB-Biotics, Abbott, AbbVie, Angelini, Boehringer-Ingelheim, Dainippon Sumitomo Pharma, Ferrer, Gedeon Richter, GH Research, Janssen, Lundbeck, Novartis, Otsuka, Sage, Sanofi-Aventis, Sunovion, and Takeda, outside the submitted work. CAZ is a full-time U.S. government employee. He is listed as a co-inventor on a patent for the use of ketamine and its metabolites in major depression and suicidal ideation. CAZ has assigned his patent rights to the U.S. government but will share a percentage of any royalties that may be received by the government. NJ and PMT received partial grant support from Biogen, Inc. (Boston, USA) for research unrelated to this manuscript. NV has received financial support for CME activities and travel funds from the following entities (unrelated to the present work): Angelini, Janssen, Lundbeck, Otsuka. EO has received consultancy honoraria from Janssen Cilag. KJR serves on advisory boards for Takeda, Janssen, and Verily, and he has received sponsored research support from Alkermes, Alto Neuroscience, and Brainsway, and he receives funding from NIH and the Brain and Behavior Research Fund. JDS has received funding via an honorarium associated with a lecture for Wyeth and funding from Indivior for a study on opioid dependency. DJS has received research grants and/or consultancy honoraria from Lundbeck, Johnson & Johnson, Servier, and Takeda.
Data Availability
NA
